The review article discusses risk factors, modern clinical and diagnostic criteria for placenta previa. Various methods of treatment and surgical management of pregnant women with pathologi-cal placenta previa are shown.
Jeon H., Min J., Kim D.K., Seo H., Kim S., Kim Y.S. Women with endometriosis, especially those who conceived with assisted reproductive technology, have increased risk of placenta previa: metaanalyses. // J. Korean Med. Sci. 2018, vol. 33, e234. DOI:10.3346/jkms.2018.33. e234 [PubMed]
Balachandar K., Melov S.J., Nayyar R. The risk of adverse maternal outcomes in cases of placenta praevia in an Australian population between 2007 and 2017. // J. Obstet Gynaecol. 2020, vol. 60, p. 890-895. DOI:10.1111/ajo.13172 [PubMed]
Bhide A., Sebire N., Abuhamad A., Acharya G. et.al. (2017) "Morbidly adherent placenta: the need for standardization." Journal of Ultrasound in Obstetrics and Gynecology, Vol. 49(5), pp. 559-563. DOI: 10.1002/uog.17417; PMID: 28120421.
Bluth A., Schindelhauer A., Nitzsche K., Wimberger P. et. al. Placenta accreta spectrum disordersexperience of management in a German tertiary perinatal centre. // J. Arch. Gynecol. Obstet. 2021 Jun; vol. 303(6), p. 1451‐1460. PMID: 33284419 PMCID: PMC8087589 DOI: 10.1007/s00404‐020‐05875‐x
Morfaw F., Fundoh M., Bartoszko J., Mbuagbaw L. Using tocolysis in pregnant women with symptomatic placenta praevia does not significantly improve prenatal, perinatal, neonatal and maternal outcomes: a systematic review and meta‐analysis. // J. Systematic Reviews. 2018, vol. 7(1),
article number: 249; DOI: 10.1186/s13643‐018‐0923‐2
Silver R.M., Barbour K.D. Placenta accreta spectrum: accreta, increta, and percreta. // J. Obstet. Gynecol. Clin. North. Am. 2015 Jun; vol. 42(2), p. 381‐402; PMID: 26002174 DOI: 10.1016/j.ogc.2015.01.014
Marcellin L., Delorme P., Pierre M.B. et. al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accrete. // Am. J. Obstet. Gynecol. 2018 Aug; vol. 219(2), p. 193.e1‐ 193.e9; PMID: 29733839 DOI: 10.1016/j.ajog.2018.04.049
Haunschild C., Yeaton‐Massey A., Lyell D.J. Antenatal Management of Placenta Accreta. // J. Clin. Obstet. Gynecol. 2018 Dec; vol. 61(4), p. 766‐773; PMID: 30204620 DOI: 10.1097/GRF.0000000000000394
Zhou Chunhua, Zhao Yang, Licorresponding Yongmei. Clinical Analysis of Factors Influencing the Development of Placenta Praevia and Perinatal Outcomes in First‐Time Pregnant Patients. // J. Front. Surg. 2022, vol. 9, e 862655; PMCID: PMC8980226; PMID: 35392051; DOI: 10.3389/fsurg.2022.862655
Carusi D.A., Fox K.A., Lyell D.J., Perlman N.C., Aalipour S., Einerson B.D. et al. Placenta accreta spectrum without placenta previa. // J. Obstet. Gynecol. 2020, vol. 136, p. 458‐465. DOI:10.1097/AOG.0000000000003970 [PubMed]
Park H.S., Cho H.S. Management of massive hemorrhage in pregnant women with placenta previa. // J. Anesth. Pain Med. (Seoul). 2020, vol. 15, p. 409‐416 10.17085/apm.20076 [PubMed]
Kingdom J.C., Hobson S.R., Murji A., Allen L, Windrim R.C., Lockhart E., et al. Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020. // Am. J. Obstet. Gynecol. 2020, vol. 223, p. 322 ‐ 329. DOI:10.1016/j.ajog.2020.01.044 [PubMed]
Shainker S.A., Coleman B., Timor‐Tritsch I.E., Bhide A., Bromley B., Cahill A.G., et al. Society for maternal‐fetal medicine. Special Report of the Society for Maternal‐Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum. // Am. J. Obstet. Gynecol. 2021, vol. 224, B2–B14. DOI:10.1016/j.ajog.2020.09.001 [PubMed]
Takeda S., Takeda J., Makino S. Cesarean section for placenta previa and placenta previa accreta spectrum. // Surg. J. (NY). 2020, vol. 6, S110‐S21. DOI:10.1055/s‐0039‐3402036 [PubMed]
King L.J., Mackeen D.A, Nordberg C., Paglia M.J. Maternal risk factors associated with persistent placenta previa. // J. Placenta. 2020, vol. 99, p. 189‐192. DOI:10.1016/j.placenta.2020.08.004 [PubMed]
Jansen CH.J.R., Kleinrouweler C.E., van Leeuwen L, Ruiter L, Mol B.W., Pajkrt E. Which second trimester
placenta previa remains a placenta previa in the third trimester: a prospective cohort study. // Eur. J.
Obstet. Gynecol. Reprod. Biol. 2020, vol. 254, p.119‐123. DOI: 10.1016/j.ejogrb.2020.08.038 [PubMed]
Ueno Y., Kitajima K., Kawakami F., Maeda T., Suenaga Y., Takahashi S. et al. Novel MRI finding for diagnosis of invasive placenta praevia: evaluation of find‐ings for 65 patients using clinical and histopathological correlations. // J. Eur. Radiol. 2014 vol. 24, p. 881‐888. DOI:10.1007/s00330‐013‐3076‐7 [PubMed]
Ma Y., You Y., Jiang X., Lin X. Use of nitroglycerin for parallel transverse uterine cesarean section in patients with pernicious placenta previa and placenta accrete and predicted difficult airway: acase report and review of literature. // J. Medicine (Baltimore). 2020, vol. 99,e18943. DOI:10.1097/MD.0000000000018943 [PubMed]
Wan Adnan W.F., Shamsudin F., Mohamad Zon E. Uterine torsion in patient with major placenta previa. // Eur. J. Obstet. Gynecol. Reprod. Biol. 2021, vol. 258, p. 467‐469. DOI:10.1016/j.ejogrb.2020.12.007 [PubMed]